ISRCTN14871374
Completed
未知
Development of wound healing therapies: a randomised controlled single-blind prospective pilot study for the use of autologous keratinocytes on a transfer dressing (TranCell) in the treatment of diabetic ulcers
CellTran Ltd (UK)0 sites16 target enrollmentJuly 22, 2005
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diabetic foot ulcer
- Sponsor
- CellTran Ltd (UK)
- Enrollment
- 16
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients with type one or type two diabetes of any age over 18 years who give written informed consent
- •2\. The presence of one or more uncomplicated pure neuropathic foot ulcers of at least four weeks duration with a cross sectional area of 0\.5 cm^2 or greater on the toes or plantar surface of the forefoot
- •3\. If patients have more than one suitable ulcer at the time of entry into the study, the ulcer of the greatest duration will be selected as the index ulcer for the study
Exclusion Criteria
- •1\. Those who withhold, or are unable to give a written informed consent
- •2\. Those with ischaemic toes or both foot pulses (dorsalis pedis, posterior tibial) impalpable on the affected foot
- •3\. Those who are allergic to the antibiotics used in the culture of the cells (penicillin, streptomycin, or amphotericin)
- •4\. Those unable to attend for dressing changes at the required frequency
- •5\. Those who are, or might become, pregnant during the course of the study
- •6\. Acute Charcot neuropathic osteoarthropathy
- •7\. Those who have skin conditions which may affect healing (e.g. psoriasis) or are on treatments which may impair wound healing (such as systemic steroids or immunosuppressants)
- •8\. Those judged not to be sufficiently compliant with recommendations concerning the off\-loading and the requirements of TranCell dressing changes
- •9\. Those in whom revascularisation or other surgical procedures to the affected limb are likely to be considered during the time course of the study
- •10\. Clinically significant active infection (involving soft tissue or bone)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
investigation of therapy for wound healing and wrinkle used conditioned mediumJPRN-UMIN000004149nagoya university,oral and maxillofacial surgery100
Not yet recruiting
Phase 2
Management of wound by a polyherbal ointment.CTRI/2024/08/071948Shri BMK AMV
Not yet recruiting
Phase 2
Management of wound by an ayurvedic ointment.Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhereCTRI/2024/07/070969Shri BMK AMV
Unknown
Phase 4
An effectiveness of progressive wound healing between silver nanoparticles based hydrogel and hydrogel in diabetic foot ulcer at Siriraj Hospital : A randomized controlled traildiabetic foot ulcer treatmenthydrogelsilver nano particle hydrogelsilver hydrogeldiabetic foot UlcerDM footTCTR20220505004Department of orthopaedic surgery78
Not yet recruiting
Phase 3
An Ayurvedic drug trial on chronic woundsHealth Condition 1: L984- Non-pressure chronic ulcer of skin, not elsewhere classifiedCTRI/2024/06/069115Department of Shalyatantra